M&A / Property
TerrAscend Signs Agreement to Acquire Fifth Dispensary in New Jersey
Small accretive NJ acquisition and reverse-split proxy fail to offset lingering debt and Michigan receivership overhang.
Executive Summary
- June 30, 2026: TerrAscend signed an option agreement to acquire a 35% interest in Aunt Mary’s Dispensary LLC (Hunterdon County, NJ) for $9M total consideration ($3M convertible promissory note + $6M cash upon exercise).
- The asset generates >$10M in annualized revenue, occupies 5,200 sq ft, and faces limited local competition.
- Management expects the transaction to be immediately accretive to EBITDA and free cash flow.
- June 29, 2026: Preliminary proxy statement filed to propose a share consolidation (reverse split) ranging from 1:5 to 1:20, targeting a special meeting on August 24, 2026 to facilitate a U.S. exchange uplisting.
- June 25, 2026: Closed a $21.7M senior secured convertible debenture financing (8% interest, matures Sept 2031) to retire higher-interest debt and fund future M&A.
Material Impact
- The Aunt Mary’s acquisition and reverse-split proxy are Routine - Positive. The $9M deal is accretive but represents a small fraction of the ~$284M market cap. The reverse split is standard corporate housekeeping to meet exchange listing requirements. The market's 8% decline since the last earnings print indicates that incremental retail expansion and corporate actions are not offsetting the deeper concerns around the Michigan receivership, debt covenants, and wholesale price compression. The news does not change the fundamental risk/reward profile materially.
TSND · Price
Company Overview
- TerrAscend Corp. is a vertically integrated cannabis operator focused on the Northeastern U.S. (New Jersey, Maryland, Pennsylvania) and Canada. The company operates a network of Apothecarium dispensaries, cultivation facilities, and manufacturing sites. It recently launched the Tyson 2.0 brand in MD and PA. The strategic focus is on margin protection, vertical integration, and preparing for a U.S. exchange uplisting following federal medical cannabis rescheduling.
More from TERRASCEND CORP. J
Jun 29, 2026 · 11:00